Longwood Fund — 2021 Investments
3 investments dated 2021 · listed companies and verified rows first · show all
BiotechCambridge, US
JOSH MANDEL-BREHM(Executive Officer, Director)RICHARD YOUNG(Director)
BoardMICHAEL HIGGINS(Director)JORGE CONDE(Director)inAMIR NASHAT(Director)in
Board seatShaan C. Gandhi· per SEC Form D · filed Oct 2021
Co-investors5AM VenturesAndreessen HorowitzPolaris Partners
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)
BoardLaura Brass(Director)inKai Wucherpfennig(Director)
Board seatChristoph Westphal· per SEC Form D
Co-investorsDC Investment PartnersMedical Excellence CapitalNovartis Venture FundOno Venture Investment, Inc.Solasta VenturesAgent Capital+2 more
Boston, US
Jim O'Connor(Executive Officer)Eileen Maus(Executive Officer, Director)
BoardTara Butler(Director)Adam Stone(Director)Dan Levangie(Director)
Board seatRich Aldrich· per SEC Form D · $19.1M raise · filed Apr 2021
Co-investorsAscension Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.